Basilea Pharmaceutica AG (SWX: BSLN)
Switzerland
· Delayed Price · Currency is CHF
45.40
-0.15 (-0.33%)
Sep 4, 2024, 5:30 PM CET
Basilea Pharmaceutica AG Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 552 | 128 | 54 | 63 | 66 | 55 | |
Market Cap Growth | 761.67% | 138.81% | -14.90% | -4.70% | 20.42% | 59.08% | |
Enterprise Value | 602 | 114 | 34 | 38 | 54 | 45 | |
Last Close Price | 45.55 | 3.49 | 1.47 | 1.93 | 2.02 | 2.26 | |
PE Ratio | - | -9.18 | -3.41 | -8.37 | -4.26 | -3.17 | |
PS Ratio | 3.68 | 3.82 | 2.99 | 4.57 | 16.40 | 21.48 | |
PB Ratio | 32.89 | 2.26 | 0.78 | 0.82 | 0.78 | 0.71 | |
P/FCF Ratio | 59.14 | -14.00 | -6.94 | -10.95 | -7.12 | -5.03 | |
P/OCF Ratio | -181.89 | -14.51 | -7.31 | -11.56 | -7.17 | -5.07 | |
EV/Sales Ratio | 4.04 | 3.41 | 1.90 | 2.77 | 13.27 | 17.71 | |
EV/EBITDA Ratio | -140.09 | -17.42 | -4.55 | -6.04 | -5.65 | -5.06 | |
EV/EBIT Ratio | -91.16 | -13.20 | -3.46 | -4.37 | -4.55 | -3.98 | |
EV/FCF Ratio | 64.45 | -12.48 | -4.40 | -6.65 | -5.76 | -4.15 | |
Debt / Equity Ratio | 0.03 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | |
Debt / FCF Ratio | -0.60 | -0.24 | -0.26 | -0.38 | -0.26 | -0.22 | |
Asset Turnover | 0.68 | 0.43 | 0.21 | 0.15 | 0.04 | 0.03 | |
Inventory Turnover | 1.14 | 1.27 | 1.47 | 2.33 | 1.96 | 2.96 | |
Quick Ratio | 2.08 | 1.66 | 2.20 | 2.72 | 7.69 | 6.01 | |
Current Ratio | 2.73 | 2.06 | 2.49 | 2.91 | 8.76 | 6.40 | |
Return on Equity (ROE) | -14.32% | -21.86% | -20.02% | -9.33% | -14.18% | -14.58% | |
Return on Assets (ROA) | -3.77% | -7.01% | -7.06% | -5.90% | -8.09% | -8.20% | |
Return on Capital (ROIC) | -4.54% | -8.34% | -8.20% | -6.59% | -8.81% | -9.08% | |
Earnings Yield | -0.12% | -10.70% | -27.17% | -11.95% | -17.39% | -20.45% | |
FCF Yield | 1.69% | -7.14% | -14.41% | -9.13% | -14.04% | -19.88% | |
Buyback Yield / Dilution | 17.17% | -7.91% | -3.37% | -34.86% | -53.69% | -81.36% | |
Total Shareholder Return | 17.17% | -7.91% | -3.37% | -34.86% | -53.69% | -81.36% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.